Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications Original paper

What was reviewed?

This review examined the biology, genetics, molecular mechanism, disease role, and translational applications of Clostridium perfringens enterotoxin (CPE), the primary virulence factor responsible for gastrointestinal disease caused by C. perfringens. The authors analyzed how CPE contributes to food poisoning, antibiotic-associated diarrhea, and enteric disease, with a focus on toxin production during sporulation, receptor binding, pore formation, and systemic complications. They also evaluated the genetic location of the enterotoxin gene (cpe), its mobility through conjugative plasmids and insertion sequences, and emerging therapeutic and diagnostic applications. The review integrated experimental evidence from molecular biology, structural biology, microbiology, animal models, and clinical observations to explain how toxin production links directly to disease severity and microbiome-associated pathogenesis.

Who was reviewed?

The review examined Clostridium perfringens strains capable of producing enterotoxin, primarily type A strains, which cause most human food poisoning cases, as well as type C, D, and some type E strains that carry functional or variant enterotoxin genes. These strains exist as part of the normal gut microbiota but become pathogenic when sporulation triggers enterotoxin production in the intestine. The review also evaluated mammalian hosts, including humans and experimental animal models such as mice and rabbits, to characterize toxin activity, epithelial damage, and systemic absorption. These models provided mechanistic insight into how enterotoxin-producing strains interact with intestinal epithelial cells and cause disease, particularly under microbiome-disrupting conditions such as antibiotic exposure or altered gut motility.

What were the most important findings?

The most important finding was that Clostridium perfringens enterotoxin acts as a pore-forming toxin that directly disrupts intestinal epithelial barrier integrity through highly specific interactions with claudin tight junction proteins, particularly claudin-3, claudin-4, claudin-6, claudin-8, and claudin-14, which serve as functional toxin receptors. After sporulation within the intestinal lumen, C. perfringens releases enterotoxin, which binds to claudins and oligomerizes to form membrane pores that increase calcium influx and trigger apoptosis or necrotic cell death depending on toxin concentration. This epithelial injury causes villus destruction, fluid and electrolyte loss, and diarrhea, which define clinical disease.

The microbiome-relevant major microbial association is the expansion or activation of enterotoxigenic Clostridium perfringens strains within the gut ecosystem, often following antibiotic exposure, foodborne contamination, or impaired intestinal motility, which promotes sporulation and toxin release. The cpe gene exists on either the chromosome or conjugative plasmids, and its association with mobile genetic elements facilitates horizontal gene transfer between strains, allowing commensal gut Clostridium populations to acquire pathogenic potential. Approximately 5–10% of antibiotic-associated diarrhea cases involve enterotoxin-producing C. perfringens, demonstrating its role as an opportunistic pathogen in dysbiotic microbiome environments. Additionally, toxin absorption into systemic circulation can cause enterotoxemia, leading to organ damage, electrolyte disturbances, and potentially fatal complications such as cardiac arrest.

What are the greatest implications of this review?

This review establishes Clostridium perfringens enterotoxin as a key microbiome-derived virulence factor that converts commensal gut bacteria into potent intestinal pathogens through sporulation-dependent toxin production and epithelial pore formation. The findings demonstrate that microbiome disruption, antibiotic exposure, and altered gut physiology can enable enterotoxigenic strains to expand and cause disease, highlighting the importance of microbiome stability in preventing toxin-mediated injury. The identification of claudins as toxin receptors explains the molecular basis of epithelial barrier dysfunction and provides therapeutic targets for toxin neutralization, receptor blocking, or microbiome modulation. Furthermore, the mobility of the enterotoxin gene via plasmids indicates that virulence traits can spread among gut microbial populations, increasing disease risk. These findings reinforce the importance of monitoring enterotoxigenic C. perfringens as a microbiome-associated pathogen and suggest opportunities for targeted therapeutics, vaccines, and microbiome-based prevention strategies.